Abstract
Although the use of pressurised aerosol inhalers is widespread, little is known about the actual deposition of the aerosol in the respiratory tract, since this has previously been difficult to measure. We have incorporated Teflon particles (mean diameter 2 micrometer) with aerodynamic properties similar to those of bronchodilator drug crystals into pressurised aerosol canisters. Controlled inhalations by eight patients with obstructive airways disease showed that on average 8.8% of the dose was deposited in the lungs (3.0% in the alveoli and 5.8% on the conducting airways) and 80% in the mouth. These figures are in good agreement with previous indirect estimates of deposition based on metabolic studies. The remainder of the dose was either expired (1.0%) or deposited in the aerosol actuator (9.8%). This method should have wide application for measurement of deposition patterns under various conditions and for assessment of therapeutic effects.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Camner P., Philipson K. Human alveolar deposition of 4 micron teflon particles. Arch Environ Health. 1978 Jul-Aug;33(4):181–185. doi: 10.1080/00039896.1978.10667331. [DOI] [PubMed] [Google Scholar]
- Camner P., Philipson K., Linnman L. A simple method for nuclidic tagging of monodisperse fluorocabon resin particles. Int J Appl Radiat Isot. 1971 Dec;22(12):731–734. doi: 10.1016/0020-708x(71)90136-0. [DOI] [PubMed] [Google Scholar]
- Goldberg I. S., Lourenço R. V. Deposition of aerosols in pulmonary disease. Arch Intern Med. 1973 Jan;131(1):88–91. [PubMed] [Google Scholar]
- Hensley M. J., O'Cain C. F., McFadden E. R., Jr, Ingram R. H., Jr Distribution of bronchodilatation in normal subjects: beta agonist versus atropine. J Appl Physiol Respir Environ Exerc Physiol. 1978 Nov;45(5):778–782. doi: 10.1152/jappl.1978.45.5.778. [DOI] [PubMed] [Google Scholar]
- Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967 May 6;214(5088):597–598. doi: 10.1038/214597a0. [DOI] [PubMed] [Google Scholar]
- Lawther P. J., Waller R. E. Physical hazards. Postgrad Med J. 1975;51 (Suppl 2):suppl 51–9. [PubMed] [Google Scholar]
- Lippmann M., Albert R. E. The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract. Am Ind Hyg Assoc J. 1969 May-Jun;30(3):257–275. doi: 10.1080/00028896909343120. [DOI] [PubMed] [Google Scholar]
- Pavia D., Thomson M. L. The fractional deposition of inhaled 2 and 5 mum particles in the alveolar and tracheobronchial regions of the healthy human lung. Ann Occup Hyg. 1976 Nov;19(2):109–114. doi: 10.1093/annhyg/19.2.109. [DOI] [PubMed] [Google Scholar]
- Ruffin R. E., Montgomery J. M., Newhouse M. T. Site of beta-adrenergic receptors in the respiratory tract: use of fenoterol administered by two methods. Chest. 1978 Sep;74(3):256–260. doi: 10.1378/chest.74.3.256. [DOI] [PubMed] [Google Scholar]
- Speizer F. E., Doll R., Heaf P. Observations on recent increase in mortality from asthma. Br Med J. 1968 Feb 10;1(5588):335–339. doi: 10.1136/bmj.1.5588.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tothill P., Galt J. M. Quantitative profile scanning for the measurement of organ radioactivity. Phys Med Biol. 1971 Oct;16(4):625–634. [PubMed] [Google Scholar]
- Walker S. R., Evans M. E., Richards A. J., Paterson J. W. The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther. 1972 Nov-Dec;13(6):861–867. doi: 10.1002/cpt1972136861. [DOI] [PubMed] [Google Scholar]
- Warner G. T., Oliver R. A whole-body counter for clinical measurements utilizing the 'shadow shield' technique. Phys Med Biol. 1966 Jan;11(1):83–94. doi: 10.1088/0031-9155/11/1/307. [DOI] [PubMed] [Google Scholar]